Region-specific KCC2 rescue by rhIGF-1 and oxytocin in a mouse model of Rett syndrome
Preprint
- 25 September 2021
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
Rett syndrome (RTT) is characterized by dysfunction in neuronal excitation/inhibition (E/I) balance, potentially impacting seizure susceptibility via deficits in K+/Cl- cotransporter 2 (KCC2) function. Mice lacking the Methyl-CpG binding protein 2 (MeCP2) recapitulate many symptoms of RTT, and recombinant human insulin-like growth factor-1 (rhIGF-1) restores KCC2 expression and E/I balance in MeCP2 KO mice. However, clinical trial outcomes of rhIGF-1 in RTT have been variable, and increasing its therapeutic efficacy is highly desirable. To this end, the neuropeptide oxytocin (OXT) is promising, as it also critically modulates KCC2 function during early postnatal development. We measured basal KCC2 expression levels in MeCP2 KO mice and identified three key frontal brain regions showing KCC2 alterations in young adult mice but not in postnatal P10 animals. We thus hypothesized that deficits in an IGF-1/OXT signaling crosstalk modulating KCC2 may occur in RTT during postnatal development. Consistently, we detected alterations of IGF-1 receptor (IGF-1R) and OXT receptor (OXTR) levels in those brain areas. rhIGF-1 and OXT treatments in KO mice rescued KCC2 expression in a region-specific and complementary manner. These results suggest that region-selective combinatorial pharmacotherapeutic strategies could be the most effective at normalizing E/I balance in key brain regions subtending the RTT pathophysiology.Keywords
Other Versions
- Published version: Version Cerebral Cortex, 32, preprints
This publication has 63 references indexed in Scilit:
- Abnormal Expression of Cerebrospinal Fluid Cation Chloride Cotransporters in Patients with Rett SyndromePLOS ONE, 2013
- Brain Activity Mapping inMecp2Mutant Mice Reveals Functional Deficits in Forebrain Circuits, Including Key Nodes in the Default Mode Network, that are Reversed with Ketamine TreatmentJournal of Neuroscience, 2012
- Female Mecp2+/− mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studiesHuman Molecular Genetics, 2012
- Evoked Axonal Oxytocin Release in the Central Amygdala Attenuates Fear ResponseNeuron, 2012
- Neuronal Activity Drives Localized Blood-Brain-Barrier Transport of Serum Insulin-like Growth Factor-I into the CNSNeuron, 2010
- Intranasal Oxytocin Improves Emotion Recognition for Youth with Autism Spectrum DisordersBiological Psychiatry, 2010
- Epilepsy and the natural history of Rett syndromeNeurology, 2010
- Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant miceProceedings of the National Academy of Sciences of the United States of America, 2009
- Insulin-Like Growth Factor 1 (IGF-1) Mediates the Effects of Enriched Environment (EE) on Visual Cortical DevelopmentPLOS ONE, 2007
- Associative Encoding in Anterior Piriform Cortex versus Orbitofrontal Cortex during Odor Discrimination and Reversal LearningCerebral Cortex, 2006